Asset Details
Do you wish to reserve the book?
Cancer pain assessment and management: does an institutional approach individualise and reduce cost of care?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cancer pain assessment and management: does an institutional approach individualise and reduce cost of care?
Do you wish to request the book?
Cancer pain assessment and management: does an institutional approach individualise and reduce cost of care?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cancer pain assessment and management: does an institutional approach individualise and reduce cost of care?
2023
Overview
ObjectivesTo understand individual prescribing and associated costs in patients managed with the Edinburgh Pain Assessment and management Tool (EPAT).MethodsThe EPAT study was a two-arm parallel group cluster randomised (1:1) trial, including 19 UK cancer centres. Study outcome assessments, including pain levels, analgesia and non-pharmacological and anaesthetic interventions, collected at baseline, 3–5 days and, if applicable, 7–10 days after admission. Costs calculated for inpatient length of stay (LoS), medications and complex pain interventions. Analysis accounted for the clustered nature of the trial design. In this post-hoc analysis, healthcare utilisation and costs are presented descriptively.Participants10 centres randomised to EPAT (487 patients) and 9 (449 patients) to usual care (UC).Main outcome measuresPharmacological and non-pharmacological management, complex pain interventions, length of hospital stay and costs related to these outcomes.ResultsThe mean per patient hospital cost was £3866 with EPAT and £4194 with UC, reflecting a mean LoS of 2.9 days and 3.1 days, respectively. Costs were lower for non-opioids, Non-steroidal anti-inflammatories (NSAIDs) and opioids but slightly higher for adjuvants with EPAT than with UC. The mean per-patient opioid costs were £17.90 (EPAT) and £25.80 (UC). Mean per patient costs of all medication were £36 (EPAT) and £40 (UC).Complex pain intervention costs were £117 with EPAT per patient and £90 with UC. Overall mean cost per patient was £4018.3 (95% CI 3698.9 to 4337.8) with EPAT and £4323.8 (95% CI 4060.0 to 4587.7) with UC.ConclusionsEPAT facilitated personalised medicine and may result in less opioids, more specific treatments, improved pain outcomes and cost savings.
